Wells Fargo & Company Windtree Therapeutics Inc Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.16 - $281.7 $0 - $1,126	4 Added 0.3%	1,316 $0
Q3 2022 Nov 14, 2022	BUY	$0.3 - $306.0 $11 - $11,628	38 Added 2.98%	1,312 $0
Q2 2022 Aug 12, 2022	BUY	$0.38 - $1.14 $4 - $13	12 Added 0.95%	1,274 $0
Q1 2022 May 16, 2022	BUY	$0.94 - $1.6 $5 - $9	6 Added 0.48%	1,262 $1,000
Q3 2021 Nov 15, 2021	BUY	$1.66 - $2.27 $1,930 - $2,640	1,163 Added 1250.54%	1,256 $2,000
Q2 2021 Aug 16, 2021	BUY	$1.68 - $2.79 $100 - $167	60 Added 181.82%	93 $0
Q1 2021 May 13, 2021	BUY	$2.14 - $6.18 $4 - $12	2 Added 6.45%	33 $0
Q3 2020 Nov 05, 2020	BUY	$5.5 - $9.9 $170 - $306	31 New	31 $0

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $34M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.